Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients

NCT01192243 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Toxicity
Non-small Cell Lung Cancer

Interventions

DRUG: Gefitinib
DRUG: Pemetrexed
DRUG: Cisplatin or carboplatin

Sponsor

Fudan University